Skip to main content

Hotel101 Global Announces a Joint Venture with Definitive Binding Agreements Signed for the Development of Hotel101 in Milan, Italy

HOTEL101-MILAN IS SET TO HAVE APPROX. 429 ROOMS TO RISE IN A 1.4 HECTARE PRIME SITE AT SAN DONATO MILANESE, ABOUT A 7-MINUTE DRIVE TO THE MILAN LINATE AIRPORT HOTEL101-MILAN IS EXPECTED TO GENERATE EUR85.8 MILLION IN SALES REVENUE HOTEL101-MILAN IS SET TO BECOME THE SECOND HOTEL101 IN EUROPE, AND WITH ITS 1.4 HECTARE PRIME SITE AND APPROX. 429 ROOMS IS EXPECTED TO BE ONE OF THE TOP 3 LARGEST HOTELS IN THE METROPOLITAN CITY OF MILAN BY ROOMCOUNT(Site location of Hotel101-Milan, Italy set to have approx. 429 rooms) SINGAPORE, Nov. 29, 2025 (GLOBE NEWSWIRE) — Hotel101 Global Holdings Corp. (NASDAQ Ticker: HBNB) (“Hotel101” or “Hotel101 Global”), a leading asset-light, prop-tech hospitality platform pioneering a global standardized “condotel” business model listed on the Nasdaq Stock Exchange and a subsidiary of Philippine-listed...

Continue reading

MAAS Announces Change to the Board of Directors

CHENGDU, China, Nov. 28, 2025 (GLOBE NEWSWIRE) — Maase Inc. (NASDAQ: MAAS) (“MAAS” or the “Company”) today announced the appointment of Mr. Jingkai Li as a director and the chairman of the board of directors (the “Board”), effective November 28, 2025. Mr. Li succeeds Ms. Hong Suong Nguyen, who has resigned from her positions as the chairperson and a director of the Board for personal reasons, effective on the same date. Mr. Li holds an executive master degree in business administration from Macau University of Science and Technology. His appointment reflects the Board’s confidence in his profound management expertise, forward-looking investment vision, and extensive background in the green industry. Over more than a decade leading Guangxi Qinyuan Environmental Protection Co., Ltd., he successfully built a technology-driven, cross-regional...

Continue reading

Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program

VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, announces that further to its news release dated June 30, 2025, and in accordance with the terms of a debenture indenture (the “Indenture”) between the Company and Odyssey Trust Company as the debenture trustee (the “Debenture Trustee”) dated May 29, 2023, governing the 12.0% convertible debentures of the Company in the aggregate principal amount of $1,454,000.00 (the “Convertible Debentures“), holders (each, a “Debentureholder“) representing at least 66 2/3% of the outstanding principal of the Convertible Debentures have consented to the extension of the maturity date of the...

Continue reading

Algernon Closes Second Tranche of Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) — Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces the closing of the second tranche (the “Second Tranche”) of its non-brokered private placement (the “Offering”), previously announced on November 6, 2025, with the first tranche closed on November 14, 2025. Gross proceeds from the Second Tranche totaled CAD $210,000 from the sale of 3,000,000 units (the “Units”) at an issue price of CAD $0.07 per Unit. The Company did not pay any cash finder’s fees pertaining to the Second Tranche of the Offering. The Company will use the proceeds of the Offering towards advancing its Alzheimer’s Disease (“AD”)...

Continue reading

PharmaCorp Announces Executive Transition and New Director of Business Development

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed President and Chief Operating Officer, effective December 1, 2025, as Calvin LeRoux steps aside from the President role and assumes a one-year appointment as Strategic Advisor to the Chief Executive Officer. Mr. Dale has served as PharmaCorp’s Chief Operating Officer since its inception and will now take on broader leadership responsibilities as PharmaCorp advances its national expansion strategy. “Paul’s appointment reinforces the continuity of our operating model and our confidence in his leadership,” said Alan Simpson, Executive Chairman of PharmaCorp. “His experience managing complex retail organizations and his steady execution...

Continue reading

Mondelēz Global LLC Conducts Limited Voluntary Recall of 1 SKU of RITZ Peanut Butter Cracker Sandwiches in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama

EAST HANOVER, N.J., Nov. 28, 2025 (GLOBE NEWSWIRE) — Mondelēz Global LLC announced today a voluntary recall of 70 cases of RITZ Peanut Butter Cracker Sandwiches and sold in the following U.S. states: New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama. This recall is limited to 1 SKU and 2 Code Dates previously recalled in July. This action is not an expansion of that prior recall and is being conducted out of an abundance of caution. The affected cartons include individually wrapped packs that may be incorrectly labeled as Cheese variety even though the product may be a Peanut Butter variety. People who have an allergy or severe sensitivity to peanuts may risk serious or life-threatening allergic reactions by consuming this product. All outer cartons affected are labeled correctly and provide...

Continue reading

AYURCANN REPORTS Q1 2026 SALES OF $14,638,697

Toronto, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce its financial and operational results for the three months ended September 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company’s full set of unaudited condensed interim consolidated financial statements for the three months ended September 30, 2025 and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca. Q1 2026 Highlights: Consistent Execution Revenue: Ayurcann generated $14,638,697 in gross revenue, with gross profit of $2,236,343 and a healthy gross margin of 26% in Q1 2026 (vs. $14,657,485...

Continue reading

ERES Enters Into Agreements to Sell Three Properties for €68 Million

TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (“ERES” or “the REIT”) (TSX:ERE.UN) announced today that it has entered into agreements to sell three properties containing a total of 322 residential suites in the Netherlands for approximately €67.8 million in combined consideration. All amounts disclosed herein exclude transaction costs and other customary adjustments. Through certain of its subsidiaries, ERES has entered into separate agreements to sell:An unencumbered 33-suite property in Roermond for approximately €10.0 million; An unencumbered 88-suite property in Valkenburg for approximately €15.0 million; and A property containing 201 suites in Arnhem for approximately €42.8 million, with part of the proceeds to be used to repay approximately €15.2 million in associated mortgage...

Continue reading

AS Silvano Fashion Group Consolidated Interim Financial Report for Q3 and 9m of 2025 (unaudited

Selected Financial Indicators Summarized selected financial indicators of the Group for 09 months of 2025 compared to 09 months of 2024 and 30.09.2025 compared to 31.12.2024 were as follows:in thousands of EUR 09m 2025 09m 2024 ChangeRevenue 44 379 46 489 -4.5%Gross Profit 24 230 27 232 -11.0%Operating profit 10 258 14 452 -29.0%EBITDA 12 810 16 724 -23.4%Net profit for the period 8 985 10 705 -16.1%Net profit attributable equity holders of the Parent company 8 281 9 711 -14.7%Earnings per share (EUR) 0,23 0,27 -14.8%Operating cash flow for the period 6 866 11 251 -39.0%       in thousands of EUR 30.09.2025 31.12.2024 ChangeTotal assets 91 827 84 489 8.7%Total current assets 78 210 70 871 10.4%Total equity attributable to equity holders of the Parent company 74 672 65 993 13.2%Cash and cash...

Continue reading

Springbig and Meadow Unveil a Seamless Loyalty + POS Integration Built for High-Performance Cannabis Retail

BOCA RATON, Fla., Nov. 28, 2025 (GLOBE NEWSWIRE) — Springbig, the leading provider of loyalty, SMS, and customer engagement technology for regulated industries, today announced a new strategic integration with Meadow, one of the most trusted cannabis point-of-sale and retail operations platforms. The partnership brings real-time loyalty, data, and marketing automation directly into the in-store checkout experience — giving retailers a faster, smarter way to drive repeat visits and higher customer value. A Unified Loyalty Experience at Checkout Through the Springbig x Meadow integration, retailers can now:Automatically sync customer profiles and purchase history from Meadow into Springbig Award and redeem loyalty points instantly at the point of sale Trigger personalized SMS and app messages based on live shopper behavior Access...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.